The Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting, held from May 5-9 in Seattle, Washington, served as a crucial platform for sharing the latest advancements in eye and vision research. For the inherited retinal disease (IRD) community, this conference brought forth promising updates from various companies and institutions, highlighting ongoing efforts to understand, diagnose, and treat these complex conditions.
Advancements in IRD Research
Several presentations at ARVO 2024 offered new insights relevant to patients and families affected by IRDs. For instance, eyeDNA, a subsidiary of Coave Therapeutics, presented on